2021
DOI: 10.3390/ijms221910667
|View full text |Cite
|
Sign up to set email alerts
|

Generation of Mesenchymal Cell Lines Derived from Aged Donors

Abstract: Background: Mesenchymal stromal cells (MSCs) have the capacity for self-renewal and multi-differentiation, and for this reason they are considered a potential cellular source in regenerative medicine of cartilage and bone. However, research on this field is impaired by the predisposition of primary MSCs to senescence during culture expansion. Therefore, the aim of this study was to generate and characterize immortalized MSC (iMSC) lines from aged donors. Methods: Primary MSCs were immortalized by transduction … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 79 publications
1
6
0
Order By: Relevance
“…However, the development of such treatment requires the in vitro expansion of cells for a long period of time, which has the disadvantage that the biological material is quickly depleted and additional isolation of primary ADSC is needed, which could negatively impact the variability of the cell products. This depletion is due to the cell senescence occurring during in vitro propagation due to telomere shortening which leads to the decline of cell growth and modification of their properties [ 13 , 14 ]. This issue could be overcome by immortalization of cells, which can be attained by transduction of genes, such as the human telomerase reverse transcriptase (hTERT) [ 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…However, the development of such treatment requires the in vitro expansion of cells for a long period of time, which has the disadvantage that the biological material is quickly depleted and additional isolation of primary ADSC is needed, which could negatively impact the variability of the cell products. This depletion is due to the cell senescence occurring during in vitro propagation due to telomere shortening which leads to the decline of cell growth and modification of their properties [ 13 , 14 ]. This issue could be overcome by immortalization of cells, which can be attained by transduction of genes, such as the human telomerase reverse transcriptase (hTERT) [ 15 , 16 , 17 ].…”
Section: Introductionmentioning
confidence: 99%
“…There were no significant differences between OA and non-OA iACs regarding proliferation capacity. However, the generation time of both OA and non-OA iACs was significantly higher in comparison with previously immortalized MSCs (mean 2.0 days (SE 0.7)) 26,33 (p = 0.001). Immortalized chondrocytes were grown over 40 PDs, and regression analysis showed a constant proliferation rate, with a multiple correlation coefficient R > 0.95 (Figure 2a) for both OA and non-OA iACs, and a p-value < 0.001.…”
Section: Resultsmentioning
confidence: 71%
“…Although intranuclear localization of hTERT is regulated by the cell cycle phase, SV40LT transduction has been described to promote the release of telomerase from nucleoli to the nucleoplasm. 28 Immortalization with these transgenes allowed chondrocytes to bypass senescence, as evidenced by the absence of granular content related to SA-β-Gal activity, similarly to immortalized MSCs, 33,42,43 and unlike primary articular chondrocytes derived from aged donors and hTERT-transduced chondrocytes. 23 However, mean generation time of immortalized chondrocytes was higher than that previously shown for immortalized MSCs, 33 suggesting that immortalized chondrocytes retain a higher degree of differentiation than immortalized MSCs.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, it affects the direction of differentiation, making MSCs an ideal cell source. Diverse immortalized MSCs cell lines based on TERT have been developed (Table 1) [54,[84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100] to improve their convenience and feasibility for clinical use.…”
Section: Issues On the Clinical Use Of Mscsmentioning
confidence: 99%